Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FYP23
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,758
Award facts
- Contract value 100% obligated
- $32,758.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $32,758.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. The contract, which carries no set-aside designation, is scheduled for completion by June 24, 2025, with an award date of June 2, 2025. This delivery order supports the pharmaceutical supply needs of Department of Defense healthcare facilities and represents a single transaction under DMS Pharmaceutical Group's broader federal procurement activities.
This delivery order is issued under DMS Pharmaceutical Group's significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The parent IDC enables the DLA to issue firm fixed-price delivery orders across an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group has established itself as a crucial supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in defense procurement markets and consistently deliver specialized medical products to military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FYP23?
SPE2DB25FYP23 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FYP23 worth?
The government has obligated $32,758 on SPE2DB25FYP23.
Is contract SPE2DB25FYP23 an order under another contract?
Yes. SPE2DB25FYP23 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP23 competed?
The extent of competition for SPE2DB25FYP23 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award